June 2020 // Communication

Updated: Mar 19, 2021

Synendos Therapeutics received a prestigious European grant (SME Instrument Phase I, TWO-BIRDS project ) that helped the company to head towards clinical trials. The European commission is now reporting about the results and the perspectives to treat post-traumatic stress disorder (PTSD) and other neuropsychiatric diseases. Read the full article here.



Recent Posts

See All

In a last newsletter edition from NCCR Transcure, we can look behind the scenes of our technology transfer success story.

Lichtsteiner Foundation Testimonial Film about Synendos We are delighted to share the testimonial film created by the Lichtsteiner Foundation. Co-founder and CEO Andrea Chicca gives insights into entr